<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Palomer E</submitter><funding>Alzheimers Research UK</funding><funding>Alzheimer&amp;apos;s Research UK (ARUK)</funding><funding>Alzheimer's Society</funding><funding>Alzheimer&amp;amp;apos;s Research UK</funding><pagination>3024-3033</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9205772</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(7)</volume><pubmed_abstract>Growing evidence supports a role for deficient Wnt signalling in Alzheimer's disease (AD). First, the Wnt antagonist DKK1 is elevated in AD brains and is required for amyloid-β-induced synapse loss. Second, LRP6 Wnt co-receptor is required for synapse integrity and three variants of this receptor are linked to late-onset AD. However, the expression/role of other Wnt signalling components remain poorly explored in AD. Wnt receptors Frizzled1 (Fzd1), Fzd5, Fzd7 and Fzd9 are of interest due to their role in synapse formation/plasticity. Our analyses showed reduced FZD1 and FZD7 mRNA levels in the hippocampus of human early AD stages and in the hAPP&lt;sup>NLGF/NLGF&lt;/sup> mouse model. This transcriptional downregulation was accompanied by reduced levels of the pro-transcriptional histone mark H4K</pubmed_abstract><journal>Molecular psychiatry</journal><pubmed_title>Epigenetic repression of Wnt receptors in AD: a role for Sirtuin2-induced H4K16ac deacetylation of Frizzled1 and Frizzled7 promoters.</pubmed_title><pmcid>PMC9205772</pmcid><funding_grant_id>ARUK-2018DDI-UCL</funding_grant_id><funding_grant_id>AS-PG-17-006</funding_grant_id><funding_grant_id>ARUK-PG2018A-002</funding_grant_id><pubmed_authors>Martin-Flores N</pubmed_authors><pubmed_authors>Whiting P</pubmed_authors><pubmed_authors>Vaher K</pubmed_authors><pubmed_authors>Saito T</pubmed_authors><pubmed_authors>Palomer E</pubmed_authors><pubmed_authors>Pascual-Vargas P</pubmed_authors><pubmed_authors>Salinas PC</pubmed_authors><pubmed_authors>Saido TC</pubmed_authors><pubmed_authors>Jolly S</pubmed_authors><pubmed_authors>Podpolny M</pubmed_authors><pubmed_authors>Teo S</pubmed_authors><pubmed_authors>Benvegnu S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epigenetic repression of Wnt receptors in AD: a role for Sirtuin2-induced H4K16ac deacetylation of Frizzled1 and Frizzled7 promoters.</name><description>Growing evidence supports a role for deficient Wnt signalling in Alzheimer's disease (AD). First, the Wnt antagonist DKK1 is elevated in AD brains and is required for amyloid-β-induced synapse loss. Second, LRP6 Wnt co-receptor is required for synapse integrity and three variants of this receptor are linked to late-onset AD. However, the expression/role of other Wnt signalling components remain poorly explored in AD. Wnt receptors Frizzled1 (Fzd1), Fzd5, Fzd7 and Fzd9 are of interest due to their role in synapse formation/plasticity. Our analyses showed reduced FZD1 and FZD7 mRNA levels in the hippocampus of human early AD stages and in the hAPP&lt;sup>NLGF/NLGF&lt;/sup> mouse model. This transcriptional downregulation was accompanied by reduced levels of the pro-transcriptional histone mark H4K</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2025-04-22T21:09:16.18Z</modification><creation>2024-12-04T10:10:12.337Z</creation></dates><accession>S-EPMC9205772</accession><cross_references><pubmed>35296808</pubmed><doi>10.1038/s41380-022-01492-z</doi></cross_references></HashMap>